Erdheim-Chester disease: diffusion-weighted imaging and dynamic contrast-enhanced MRI provide useful information.

18FDG PET-CT CT Diffusion-weighted imaging Dynamic contrast-enhanced MRI Erdheim-Chester disease Imaging Radiology SPECT Treatment response X-ray

Journal

Skeletal radiology
ISSN: 1432-2161
Titre abrégé: Skeletal Radiol
Pays: Germany
ID NLM: 7701953

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 22 08 2022
accepted: 12 12 2022
revised: 09 12 2022
medline: 19 6 2023
pubmed: 6 1 2023
entrez: 5 1 2023
Statut: ppublish

Résumé

This is, to our knowledge, the first case report with in-depth analysis of bone marrow and bone lesions with diffusion-weighted imaging and dynamic contrast-enhanced MRI in Erdheim-Chester disease to date. We present a case of a 70-year-old woman who was referred for an X-ray of the pelvis, right femur and right knee after complaints of migratory arthralgia in hip and knee five months after an initial hip and knee trauma. Bone lesions on X-ray were identified. This case report highlights the strength and complementary use of modern multimodality multiparametric imaging techniques in the clinical radiological manifestations of Erdheim-Chester disease, in the differential diagnosis and in treatment response assessment, which is classically performed using

Identifiants

pubmed: 36602575
doi: 10.1007/s00256-022-04265-5
pii: 10.1007/s00256-022-04265-5
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1605-1618

Informations de copyright

© 2023. The Author(s), under exclusive licence to International Skeletal Society (ISS).

Références

Haroche J, Cohen-Aubart F, Amoura Z. Erdheim-Chester disease. Blood. 2020;135(16):1311–8.
doi: 10.1182/blood.2019002766 pubmed: 32107533
Mazor RD, Manevich-Mazor M, Shoenfeld Y. Erdheim-Chester disease: a comprehensive review of the literature. Orphanet J Rare Dis. 2013;8:137.
doi: 10.1186/1750-1172-8-137 pubmed: 24011030 pmcid: 3849848
Goyal G, Heaney ML, Collin M, et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood. 2020;135(22):1929–45.
doi: 10.1182/blood.2019003507 pubmed: 32187362
Diamond EL, Dagna L, Hyman DM, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014;124(4):483–92.
doi: 10.1182/blood-2014-03-561381 pubmed: 24850756 pmcid: 4110656
Abdelfattah AM, Arnaout K, Tabbara IA. Erdheim-Chester disease: a comprehensive review. Anticancer Res. 2014;34(7):3257–61.
pubmed: 24982329
Haroche J, Charlotte F, Arnaud L, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120(13):2700–3.
doi: 10.1182/blood-2012-05-430140 pubmed: 22879539
Dutoit JC, Claus E, Offner F, Noens L, Delanghe J, Verstraete KL. Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma. Eur J Radiol. 2016;85(2):373–82.
doi: 10.1016/j.ejrad.2015.11.040 pubmed: 26781143
Dutoit JC, Verstraete KL. Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma. Skeletal Radiol. 2017;46(6):733–50.
doi: 10.1007/s00256-017-2609-6 pubmed: 28289855
Van Den Berghe T, Verstraete KL, Lecouvet FE, Lejoly M, Dutoit J. Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma). Skeletal Radiol. 2022;51(1):101–22.
doi: 10.1007/s00256-021-03903-8 pubmed: 34523007
Joshua DE, Bryant C, Dix C, Gibson J, Ho J. Biology and therapy of multiple myeloma. Med J Aust. 2019;210(8):375–80.
doi: 10.5694/mja2.50129 pubmed: 31012120
Starkebaum G, Hendrie P. Erdheim-Chester disease. Best Pract Res Clin Rheumatol. 2020;34(4):101510.
doi: 10.1016/j.berh.2020.101510 pubmed: 32305313
Garg N, Lavi ES. Clinical and neuroimaging manifestations of Erdheim-Chester disease: a review. J Neuroimaging. 2021;31(1):35–44.
doi: 10.1111/jon.12785 pubmed: 32920940
Cives M, Simone V, Rizzo FM, et al. Erdheim-Chester disease: a systematic review. Crit Rev Oncol Hematol. 2015;95(1):1–11.
doi: 10.1016/j.critrevonc.2015.02.004 pubmed: 25744785
Knitza J, Kampylafka E, Wacker J, Schett G, Manger B. Erdheim-Chester disease: an important differential diagnosis and its main symptoms. Z Rheumatol. 2019;78(1):66–71.
doi: 10.1007/s00393-018-0566-7 pubmed: 30430236
Campochiaro C, Tomelleri A, Cavalli G, Berti A, Dagna L. Erdheim-Chester disease. Eur J Intern Med. 2015;26(4):223–9.
doi: 10.1016/j.ejim.2015.03.004 pubmed: 25865950
Munoz J, Janku F, Cohen PR, Kurzrock R. Erdheim-Chester disease: characteristics and management. Mayo Clin Proc. 2014;89(7):985–96.
doi: 10.1016/j.mayocp.2014.01.023 pubmed: 24814521
Antunes C, Graça B, Donato P. Thoracic, abdominal and musculoskeletal involvement in Erdheim-Chester disease: CT, MR and PET imaging findings. Insights Imaging. 2014;5(4):473–82.
doi: 10.1007/s13244-014-0331-7 pubmed: 25017251 pmcid: 4141342
Haroche J, Papo M, Cohen-Aubart F, et al. Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia. Presse Med. 2017;46(1):96–106.
doi: 10.1016/j.lpm.2016.02.025 pubmed: 27234902
Choraria A, Andrei V, Rajakulasingam R, Saifuddin A. Musculoskeletal imaging features of non-Langerhans cell histiocytoses. Skeletal Radiol. 2021;50(10):1921–40.
doi: 10.1007/s00256-021-03765-0 pubmed: 33787962
Wang F, Cao X, Niu N, et al. Multisystemic imaging findings in Chinese patients with Erdheim-Chester disease. AJR Am J Roentgenol. 2019;213(6):1179–86.
doi: 10.2214/AJR.19.21523 pubmed: 31532257
Kumar P, Singh A, Gamanagatti S, Kumar S, Chandrashekhara SH. Imaging findings in Erdheim-Chester disease: what every radiologist needs to know. Pol J Radiol. 2018;83:e54–62.
doi: 10.5114/pjr.2018.73290 pubmed: 30038679 pmcid: 6047091
Moulis G, Sailler L, Bonneville F, Wagner T. Imaging in Erdheim-Chester disease: classic features and new insights. Clin Exp Rheumatol. 2014;32(3):410–4.
pubmed: 24428974

Auteurs

Thomas Van Den Berghe (T)

Department of Radiology, Ghent University Hospital and Ghent University, Ghent, Belgium. thovdnbe.VanDenBerghe@ugent.be.

Esther Candries (E)

Department of Radiology, Ghent University Hospital and Ghent University, Ghent, Belgium.

Nicolas Everaert (N)

Department of Radiology, Ghent University Hospital and Ghent University, Ghent, Belgium.

Michael Saerens (M)

Department of Oncology, Ghent University Hospital and Ghent University, Ghent, Belgium.

Jo Van Dorpe (J)

Department of Pathology, Ghent University Hospital and Ghent University, Ghent, Belgium.

Koenraad Verstraete (K)

Department of Radiology, Ghent University Hospital and Ghent University, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH